Comparing Data Generated Using Multiparametric Flow Cytometry, Capillary Electrophoresis, and Next-Generation Sequencing in a Cohort of B-Cell Lymphoproliferative Disorder Sampleswmm2022-12-29T21:22:21-08:00November 15th, 2022|Read more
LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patientswmm2022-12-29T21:19:31-08:00June 4th, 2022|Read more
Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?wmm2023-01-08T18:20:36-08:00May 30th, 2022|Read more
Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myelomaInvivoscribe Marketing2022-09-07T22:22:23-07:00May 3rd, 2022|Read more
Ig Gene Clonality Analysis Using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patientswmm2022-01-06T05:38:03-08:00January 4th, 2022|Read more
Invivoscribe Diagnostic Technologies (Shanghai) Co. Ltd. Receives CAP Accreditation to Support Clinical Research Testing for Pharmaceutical Partners in ChinaInvivoscribe Marketing2023-02-23T06:28:40-08:00February 23rd, 2023|Read more
Invivoscribe Appoints Masato Sasaki as General Manager of LabPMM, GK (Japan)Invivoscribe Marketing2023-02-01T21:02:16-08:00February 1st, 2023|Read more
Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AMLwmm2022-10-24T14:57:12-07:00October 24th, 2022|Read more
Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio’s Investigational Compound Being Developed for Patients with AMLInvivoscribe Marketing2022-08-16T20:08:13-07:00August 16th, 2022|Read more
Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicinewmm2022-05-09T17:27:05-07:00May 9th, 2022|Read more
ASH 2023December 9-12, 2023 San Diego, CA On-site Booth https://www.hematology.org/meetings/annual-meeting
EAHP-SH 2023November 9 – 11, 2023 Houston, Texas On-site Booth & Symposium https://www.society-for-hematopathology.org/2023/
JSH 2023October 13-15, 2023 Tokyo, Japan Corporate Sponsorship (symposium) http://www.jshem.or.jp/85/en/index.html